Reps. Burgess, Schwartz Bill Would Exempt Indirect Payments For CME From Reporting

September 19, 2014 at 5:01 PM
Reps. Michael Burgess (R-TX) and Allyson Schwartz (D-PA) introduced bipartisan legislation Friday (Sept. 19) that would exempt indirect payments that drug and device manufacturers offer to continuing medical education providers from sunshine reporting requirements, legislation that if enacted would reverse CMS' plan to do away with the exemption. The legislation comes on the heels of a letter sent to CMS Thursday (Sept.18) by Burgess and Rep. Frank Pallone Jr. (D-NJ) expressing their concern over the agency's plan to do away...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.